07 Sept 2023
15m

S9 Ep24: FDA Approval Insights: Talquetamab in Relapsed/Refractory Multiple Myeloma

Podcast cover

OncLive® On Air

Open in Podwise to generate AI notes

Sign in to process this episode and unlock summaries, transcripts, highlights and translations.

Open in Podwise

Shownotes are not generated by Podwise.

S9 Ep24: FDA Approval Insights: Talquetamab in Relapsed/Refractory Multiple Myeloma